Cargando…
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease
Huntington’s disease is an autosomal dominant neurodegenerative disease caused by abnormal polyglutamine expansion in huntingtin (Exp-HTT) leading to degeneration of striatal neurons. Altered brain cholesterol homeostasis has been implicated in Huntington’s disease, with increased accumulation of ch...
Autores principales: | Boussicault, Lydie, Alves, Sandro, Lamazière, Antonin, Planques, Anabelle, Heck, Nicolas, Moumné, Lara, Despres, Gaëtan, Bolte, Susanne, Hu, Amélie, Pagès, Christiane, Galvan, Laurie, Piguet, Francoise, Aubourg, Patrick, Cartier, Nathalie, Caboche, Jocelyne, Betuing, Sandrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766376/ https://www.ncbi.nlm.nih.gov/pubmed/26912634 http://dx.doi.org/10.1093/brain/awv384 |
Ejemplares similares
-
Multiple Aspects of Gene Dysregulation in Huntington’s Disease
por: Moumné, Lara, et al.
Publicado: (2013) -
Altered Cholesterol Homeostasis in Huntington’s Disease
por: Kacher, Radhia, et al.
Publicado: (2022) -
Huntington’s Disease and Striatal Signaling
por: Roze, Emmanuel, et al.
Publicado: (2011) -
Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter
por: Martin, Elodie, et al.
Publicado: (2011) -
Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum
por: Pinchaud, Katleen, et al.
Publicado: (2023)